Strauss Borrelli PLLC, a leading data breach law firm, is investigating Advarra, Inc. regarding its recent data breach. The Advarra data breach involved sensitive personal identifiable information belonging to over 1,700 individuals.
ABOUT ADVARRA, INC.:
Advarra is a pharmaceutical manufacturing and consulting company focused on clinical research and clinical trial management. Founded in 1983, Advarra’s integrated solutions make clinical research safer by helping safeguard trial participants, empowering clinical sites, ensuring compliance, and optimizing research performance. Today, Advarra is a leading provider of institutional review boards (IRBs), institutional biosafety committee (IBC) and research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers, and investigators. Headquartered in Columbia, Maryland, Advarra has locations across the United States, Ireland, and India. Advarra employs approximately 1,000 individuals and has annual revenue of over $250 million.
WHAT HAPPENED?
On October 26, 2023, Advarra discovered that it had experienced a data breach in which the sensitive personal identifiable information in its systems may have been accessed. Through its investigation, Advarra determined that an unauthorized third-party may have accessed this sensitive information between October 25 and October 26, 2023. On November 29, 2023, Advarra began notifying individuals whose information may have been impacted. The type of information exposed includes:
- Name
- Social Security number
If you have received a breach notification letter from Advarra, Inc.:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
